ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
| Príomhchruthaitheoir: | |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
"Paediatrician" Publishers LLC
2008-08-01
|
| Sraith: | Вопросы современной педиатрии |
| Rochtain ar líne: | https://vsp.spr-journal.ru/jour/article/view/1441 |